Old Web
English
Sign In
Acemap
>
authorDetail
>
I. Kümler
I. Kümler
Gentofte Hospital
Oral administration
Pharmacology
Tolerability
Irinotecan
Medicine
2
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.
2019
Cancer Chemotherapy and Pharmacology
I. Kümler
R. L. Eefsen
Peter G. Sørensen
S. Theile
A. Fullerton
P. G. Nielsen
Benny Vittrup Jensen
Dorte Nielsen
Show All
Source
Cite
Save
Citations (2)
Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics
2019
Cancer Chemotherapy and Pharmacology
I. Kümler
P. Grundtvig Sørensen
Jesper Andreas Palshof
Estrid Høgdall
W. Skovrider-Ruminski
S. Theile
A. Fullerton
P. G. Nielsen
B. Vittrup Jensen
Dorte Nielsen
Show All
Source
Cite
Save
Citations (5)
1